Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

[1]  E. Feskens,et al.  Mediterranean Diet and Type 2 Diabetes Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study , 2011, Diabetes Care.

[2]  Rosanna Abbate,et al.  Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. , 2010, The American journal of clinical nutrition.

[3]  R. Bosch,et al.  Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy , 2010, Diabetes Care.

[4]  S. Posner,et al.  Diabetes trends in hospitalized HIV-infected persons in the United States, 1994-2004. , 2009, Current HIV Research.

[5]  S. Grinspoon.  Diabetes mellitus, cardiovascular risk, and HIV disease. , 2009, Circulation.

[6]  O. Kirk,et al.  Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study) , 2009, Circulation.

[7]  G. Bruno,et al.  Socio-economic differences in the prevalence of diabetes in Italy: the population-based Turin study. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  A. Deshpande,et al.  Epidemiology of Diabetes and Diabetes-Related Complications , 2008, Physical Therapy.

[9]  S. Crystal,et al.  HIV infection and the risk of diabetes mellitus , 2008, AIDS.

[10]  P. Tebas.  Insulin Resistance and Diabetes Mellitus Associated With Antiretroviral Use in HIV-Infected Patients: Pathogenesis, Prevention, and Treatment Options , 2008, Journal of acquired immune deficiency syndromes.

[11]  Nina Friis-Møller,et al.  Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients , 2008, Diabetes Care.

[12]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[13]  A. Justice,et al.  Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. Cooper,et al.  Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection , 2007, AIDS.

[15]  Hang Lee,et al.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.

[16]  Avis J. Thomas,et al.  A Comparison of Factors Associated With Prevalent Diabetes Mellitus Among HIV-Infected Antiretroviral-Naive Individuals Versus Individuals in the National Health and Nutritional Examination Survey Cohort , 2007, Journal of acquired immune deficiency syndromes.

[17]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[18]  V. Soriano,et al.  Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir. , 2006, AIDS research and human retroviruses.

[19]  S. Cole,et al.  Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study , 2005, AIDS.

[20]  Stephen R Cole,et al.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. , 2005, Archives of internal medicine.

[21]  J. Bartlett.  Cost-Effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency Virus , 2004 .

[22]  O. Kirk,et al.  Combination antiretroviral therapy and the risk of myocardial infarction. , 2003, The New England journal of medicine.

[23]  A. Lazzarin,et al.  Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals , 2003, AIDS.

[24]  R. Greenblatt,et al.  Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV‐Infected Women , 2003, Journal of acquired immune deficiency syndromes.

[25]  J. Fuller,et al.  Abacavir and diabetes. , 2001, The New England journal of medicine.

[26]  D. Cooper,et al.  Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study , 1999, The Lancet.

[27]  M. Egger,et al.  Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.